LU67144A1 - - Google Patents

Info

Publication number
LU67144A1
LU67144A1 LU67144A LU67144DA LU67144A1 LU 67144 A1 LU67144 A1 LU 67144A1 LU 67144 A LU67144 A LU 67144A LU 67144D A LU67144D A LU 67144DA LU 67144 A1 LU67144 A1 LU 67144A1
Authority
LU
Luxembourg
Application number
LU67144A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of LU67144A1 publication Critical patent/LU67144A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01Five-membered rings
    • C07D285/02Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/101,2,5-Thiadiazoles; Hydrogenated 1,2,5-thiadiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50Pyridazines; Hydrogenated pyridazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
LU67144A 1972-03-06 1973-03-02 LU67144A1 (en:Method)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US00232294A US3833727A (en) 1972-03-06 1972-03-06 Hydralazine and beta-adrenergic blocking agent compositions for treating hypertension

Publications (1)

Publication Number Publication Date
LU67144A1 true LU67144A1 (en:Method) 1973-09-06

Family

ID=22872572

Family Applications (1)

Application Number Title Priority Date Filing Date
LU67144A LU67144A1 (en:Method) 1972-03-06 1973-03-02

Country Status (19)

Country Link
US (1) US3833727A (en:Method)
AT (1) AT331966B (en:Method)
BE (1) BE796288A (en:Method)
CA (1) CA1015662A (en:Method)
CY (1) CY951A (en:Method)
DD (1) DD103559A5 (en:Method)
FR (1) FR2181786B1 (en:Method)
GB (1) GB1385648A (en:Method)
HK (1) HK23378A (en:Method)
HU (1) HU165714B (en:Method)
IE (1) IE37326B1 (en:Method)
IL (1) IL41610A (en:Method)
KE (1) KE2839A (en:Method)
LU (1) LU67144A1 (en:Method)
MY (1) MY7800295A (en:Method)
NL (1) NL176746C (en:Method)
PH (1) PH18901A (en:Method)
SE (1) SE400472B (en:Method)
ZA (1) ZA731505B (en:Method)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4001421A (en) * 1971-10-27 1977-01-04 Syntex (U.S.A.) Inc. Thiazole cardiovascular agents
AU540656B2 (en) * 1980-02-19 1984-11-29 Merck & Co., Inc. S-(-)-1-(tert-butylamino-3((4-morpholino-1,2,5-thiadiazol-3- yl)-oxy)-2-propanol pamoate
US4521414A (en) * 1981-06-18 1985-06-04 The Texas A&M University System Ophthalmic compositions and their use for treating elevated intraocular pressure and glaucoma
US20110092507A1 (en) * 2009-10-20 2011-04-21 Chin-Tsai Fan Process for preparing R-(+)-3-morpholino-4-(3- tert-butylamino-2-hydroxypropoxy)-1,2,5-thiadiazole

Also Published As

Publication number Publication date
FR2181786A1 (en:Method) 1973-12-07
PH18901A (en) 1985-10-30
HK23378A (en) 1978-05-12
US3833727A (en) 1974-09-03
DE2310836A1 (de) 1973-09-20
GB1385648A (en) 1975-02-26
IL41610A (en) 1975-08-31
KE2839A (en) 1978-05-26
AU5266273A (en) 1974-08-29
NL176746B (nl) 1985-01-02
DE2310836B2 (de) 1976-11-04
NL7302728A (en:Method) 1973-09-10
MY7800295A (en) 1978-12-31
IL41610A0 (en) 1973-04-30
IE37326L (en) 1973-09-06
SE400472B (sv) 1978-04-03
ZA731505B (en) 1974-10-30
IE37326B1 (en) 1977-06-22
CA1015662A (en) 1977-08-16
FR2181786B1 (en:Method) 1976-05-14
DD103559A5 (en:Method) 1974-02-05
HU165714B (en:Method) 1974-10-28
AT331966B (de) 1976-09-10
BE796288A (fr) 1973-09-05
CY951A (en) 1978-12-22
NL176746C (nl) 1985-06-03
ATA195873A (de) 1975-12-15

Similar Documents

Publication Publication Date Title
FR2173886B1 (en:Method)
FR2178570A5 (en:Method)
FR2181786B1 (en:Method)
JPS4989532A (en:Method)
JPS5336138Y2 (en:Method)
JPS5152629Y2 (en:Method)
JPS56882B2 (en:Method)
JPS4885663A (en:Method)
JPS48104601U (en:Method)
JPS48104592A (en:Method)
JPS4895796A (en:Method)
JPS4974770A (en:Method)
JPS4961274A (en:Method)
JPS4885805U (en:Method)
JPS4883441U (en:Method)
CH579914A5 (en:Method)
CH572229A5 (en:Method)
BG18055A1 (en:Method)
NL7303743A (en:Method)
CH570474A5 (en:Method)
CH569902A5 (en:Method)
CH578986A5 (en:Method)
CH578493A5 (en:Method)
CH578482A5 (en:Method)
CH577206B5 (en:Method)